Health Minister lashed over PBS subsidies ‘cap’
Katy Gallagher’s warning of a new ‘reality’ for medicine subsidies sits at odds with promises of faster bureaucracy, as the government navigates drug delays.
Katy Gallagher’s warning of a new ‘reality’ for medicine subsidies sits at odds with promises of faster bureaucracy, as the government navigates drug delays.
Tanya Plibersek will face judicial scrutiny over her decision to heritage-list part of the Blayney gold mine site, effectively blocking the $1m project.
Mark Butler has called in the government’s drug assessor for an emergency meeting after consideration of 45 drugs – some potentially lifesaving – without consultation.
In three separate campaigns, Donald Trump has outperformed the numbers pollsters put in front of him, but 2024 analysts took solace in slight rise to accuracy.
Donald Trump vows to ‘help the US heal’, winning both the electoral college and popular vote. A win in Wisconsin confirmed his second term as president and victory over Kamala Harris.
Key evidence submitted late to Tanya Plibersek received an ‘unfair’ lack of scrutiny, avoiding assessment outside of her own office.
Pharmaceutical companies whose medicines have been indefinitely delayed are being charged $200,000 per application despite no services being provided, as patient outrage grows.
Three in 10 Indigenous Australians avoid necessary healthcare, with Indigenous health organisations under-represented, Monash is opting to change this.
Facing the threat of extinction because of fire and foxes, WA’s population of wiliji wallabies look to Indigenous rangers for salvation.
Cancer treatments and chronic-disease medications are among the drugs deferred in a shock decision by the government’s advisory body for drug subsidies, which has left 45 new medicines stalled without discussion.
Original URL: https://www.theaustralian.com.au/author/james-dowling/page/6